Feasibility of Endoscopic Submucosal Dissection: A New Technique for En Bloc Resection of a Large Superficial Tumor in the Colon and Rectum by Shono, T. et al.
Hindawi Publishing Corporation
International Journal of Surgical Oncology
Volume 2011, Article ID 948293, 6 pages
doi:10.1155/2011/948293
Clinical Study
FeasibilityofEndoscopic SubmucosalDissection:
A New Technique forEn BlocResection ofaLargeSuperﬁcial
Tumor in the Colon and Rectum
T.Shono,1 K.Ishikawa,1 Y. Ochiai,1 M. Nakao,1 O. Togawa,1 M.Nishimura,1 S.Arai,1
K.Nonaka,2 Y. Sasaki,2 and H. Kita1
1Department of Gastroenterology, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka,
Saitama 350-1298, Japan
2Department of Gastroenterology and Hepatology, Graduate School of Medical Sciences, Kumamoto University,
1-1-1 Honjo, Kumamoto 860-8556, Japan
Correspondence should be addressed to H. Kita, hkita@saitama-med.ac.jp
Received 28 December 2010; Revised 17 February 2011; Accepted 28 February 2011
Academic Editor: Michael D. Hellinger
Copyright © 2011 T. Shono et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Endoscopic submucosal dissection (ESD) is a promising procedure that enables en bloc resection of large superﬁcial tumors in
the upper gastrointestinal tract. On the other hand, ESD in the colon and rectum is technically diﬃcult to perform because of its
anatomicalfeatures. At ourinstitution,137consecutivesuperﬁcial colorectaltumorslargerthan20mmindiameter in137patients
were treated by ESD between April 2007 and October 2010,and132 lesionswere successfully resected. The averageprocedure time
was 79.2 minutes, and the rate of en bloc resection was 89.1% (122/137). The rate of complete resection, deﬁned as en bloc
resection with tumor-free lateral and vertical margins,was 85.4% (117/137).The rate of perforation was 3.6% (5/137). Colorectal
ESD achieved a high rate of en bloc resection and complete resection and is applicable in the colorectum.
1.Introduction
Colorectal neoplastic lesions sometimes extend laterally
rather than vertically, and colorectal tumor that spreads
superﬁcially was named laterally spreading tumor (LST) by
Kudoetal.[1].Theoretically,colorectalsuperﬁcial neoplastic
lesions, including LST, without lymph node metastasis
can be treated by intraluminal endoscopic resection alone.
Endoscopic mucosal resection (EMR) is widely used as
an established method for colorectal superﬁcial neoplasms
although the indication for EMR has been limited by the
snare size. Endoscopic piecemeal mucosal resection (EPMR)
and laparoscopic resection have been accepted as treatments
for large superﬁcial tumors over 20mm in the colon.
Endoscopic submucosal dissection (ESD) is widely
accepted as a reliable method that enables en bloc resection
of large superﬁcial tumors in the upper gastrointestinal (GI)
tract, including the esophagus and stomach, in Japan. By
contrast, ESD for the colorectal neoplasm has been regarded
as a technically diﬃculttherapeuticprocedure because ofthe
anatomical and histological diﬀerences between the upper
GI and the colorectum. Recently, with the development of
related equipment,colorectalESDhasgraduallybeencarried
out in Japanese institutions with favorableresults [2–10]. We
report the feasibility of this technique using our own results.
2.Materialsand Methods
2.1. Patients and Indication for Colorectal ESD. Between
April 2007 and October 2010, 137 consecutive colorectal
superﬁcial tumors in 137 patients (79 men, 58 women;
mean age 66.8 years), which fulﬁlled our indication criteria,
were treated with ESD technique, at Saitama Medical
University, International Medical Center. The colorectal ESD
standardization implementation working group suggested
the indication for colorectal ESD, as shown in Table 3 [10],
and our study was carried out based on the same criteria.2 International Journal of Surgical Oncology
Table 1: Clinicopathologic characteristics of 137 superﬁcial col-
orectal tumors.
Age, mean (range), years 66.8 (40–90)
Men, Women 79, 58
Tumor Size, mean (range), mm 29.2 (20–150)
Tumor location n
Cecum 10
Ascending Colon 26
Transverse Colon 32
Descending Colon 5
Sigmoid Colon 28
Rectum 36
Tumor Morphology n
Laterally Spreading Tumors (LST) 100
Non LST 37
Operation time, average (range), minutes 79.2min. (20–100)
En bloc resection rate, % 89.1% (122/137)
Complete resection rate, % 85.4% (117/137)
Endoscopic piecemeal resection (EPMR), % 7.3% (10/137)
Suspended, % 3.6% (5/137)
Complications
Perforation, % 3.6% (5/137)
Postoperative hemorrhage, % 3.6% (5/137)
HistopathologicalDiagnosis
Adenoma 40
Adenocarcinoma 97
Intramucosal 89
Submucosal (SM) invasion 8
SM1 3
SM2 5
Complete resection: En bloc resection with tumor-free lateral and vertical
margins.
SM1: submucosalinvasion lessthan 1000µm from the muscularismucosae.
SM2: submucosalinvasion1000µm or more fromthe muscularismucosae.
In brief, the indications for ESD were colorectal superﬁcial
neoplasia that might have a malignant component without
lymph node metastases larger than 20mm in diameter or
that are diﬃcult to completely remove with the conven-
tional EMR technique. The indication for colorectal ESD
was decided from the endoscopic features, observed with
chromoendoscopy and magnifying endoscopy with narrow
band imaging (NBI) in order to recognize the demarcated
line between normal mucosa and lesion and to estimate
the depth of the lesion. Endoscopic ultrasonography (EUS)
was also performed when conventional endoscopy raised the
suspicion of massive submucosal invasion. Written informed
consent was obtained from all patients. ESD was performed
by four endoscopists, and the therapeutic eﬃcacy and safety
were assessed.
2.2. Technical Method of Colorectal ESD. The ESD proce-
dure has been described elsewhere [11–13]. That typical
procedure of colorectal ESD is shown in Figure 1.E S D
was performed using two types of colonoscopes (PCF-
Q260AI, PCF-Q240ZI; Olympus Medical Systems, Tokyo,
Japan). A tip-transparent hood was attached to the tip of
the endoscope. A high-frequency power supply VIO300D
(ERBE Elektromedizin, Germany) was used. A ﬂush knife
(DK2618JN15; Fijinon, Tokyo, Japan) was used in 100 cases.
A hook knife (KD-620LR: Olympus, Tokyo, Japan) was
used in combination with the ﬂush knife in 7 patients
with diﬃcult dissection. A precutting knife (KD-10Q-1;
Olympus) was used in 37 cases because the ﬂush knife was
not available when we started this study. We then gradually
switched to the ﬂush knife during this study because it was
developed speciﬁcally for ESD. Carbon dioxide insuﬄation
described by Saito et al. [14] was used during colorectal ESD
in order to reduce the patient’s discomfort during and after
ESD. Conscious sedation was achieved with a small amount
of midazolam and pethidine.
Normal saline was preinjected to avoid injecting sodium
hyaluronate into the wrong layer because it is diﬃcult to
inject sodium hyaluronate solution into the appropriate
submucosal layer of the colon. Sodium hyaluronate is useful
[15] and necessary for colorectal ESD. Sodium hyaluronate
0.4% (Mucoup; Johnson & Johnson, Tokyo, Japan) mixed
with a small amount of indigo carmine dye and epinephrine
was used as the liquid for local injection into submucosal
layer. By mixing a small amount of indigo carmine dye and
epinephrine into sodium hyaluronate solution, visualization
of the submucosal layer to be dissected was much easier and
it diminished bleeding during the procedure.
The range of the colonic neoplasm was generally clear
and marking was not necessary. In most cases, mucosal
incision started from the most distant edge to determine
the end line to be dissected. To take advantage of gravity,
changing the patient’s position was important. When the
relevant dissection layer was suﬃciently visible,circumferen-
tial incision was performed. Hemostatic forceps (SDB2422;
PentaxHoya)were used tocontrolbleeding.Anyvisible large
vessels were precoagulated and cut. The resected specimen
was removed and evaluated histopathologically.
2.3. Followup. Colonoscopy was scheduled at 6 and 12
months after ESD, and then annually. Suspicious abnormali-
ties were histologically conﬁrmed by biopsy.
3.Results
The clinicopathologic characteristics of 137 patients are
described in Table 1. The mean diameter of the lesions was
29.2mm (range 20–150), and the mean procedure time for
resection was 79.2 minutes (range 20–300). Macroscopic
feature of the tumors included LST type in 100 lesions and
non-LST type in 37 lesions. The lesions were located in the
cecum (n = 10), ascending colon (n = 26), transverse colon
(n = 32), descending colon (n = 5), sigmoid colon (n = 28),
and rectum (n = 36). We tried to endoscopically resect 137
superﬁcial tumors in the colon and rectum and successfully
resected 132 superﬁcial tumors. Endoscopic treatment was
suspended in 5 cases because of strong submucosal ﬁbrosisInternational Journal of Surgical Oncology 3
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Figure 1: (a) Conventional endoscopic view with indigo carmine dye spray revealed laterally spreading tumor (LST), 40mm in diameter,
located in the rectum. The border was well demarcated. (b) After injection of sodium hyaluronate. (c) Mucosal incision and dissection. (d)
Rectal ulcer after ESD. (e) Resected specimen was 45mm × 40mm.
in 4 cases and procedure-related perforation in one case,
as shown in Table 2. En bloc resection was performed in
122 cases, with a rate of 89.1% (122/137). The remaining
ten superﬁcial tumors were resected in two to six pieces by
the combination of ESD and EMR. The rate of complete
resection, deﬁnedasenblocresection withtumor-free lateral
and vertical margins, was 85.4% (117/137) because 9 cases
were histologically judged to have a positive lateral margin
and one case a positive vertical margin.
Complications of the treatments included postoperative
hemorrhage which required clipping in 5 (3.6%) cases.
Perforations occurred during ESDin 4cases and after ESDin
onecase.TwocasesofperforationduringESDweresubjected
to surgical operation within 24 hours, including curative
resection of the tumor, while the remaining 3 cases were
curedconservativelyafterendoscopicclosureusingclips.The
histopathological diagnoses of the resected specimens were
tubular and tubulovillous adenomas in 40 cases (29.2%),
adenomas with focal carcinoma or carcinomas localized in
the mucosa in 89 cases (65%), and carcinomas with invasion
into the submucosa in 8 cases (5.8%). In eight submucosal
invasive cancers, there were three SM1 cancers and ﬁve SM2
(SM invasion 1000µm or more from muscularis mucosae),
without vessel inﬁltration. Five SM2 cancers were considered
to be at substantial risk for nodal metastasis, so laparo-
scopic colectomy and lymphadenectomy were additionally
performed and distant metastases were not detected. In the
follow-up period, there were no cases of local recurrence and
no instances of metastasis.
Our study included 132 cases of newly developed lesions
and ﬁve residual lesions that showed a non-lifting sign.
These ﬁve residual lesions were also selected and subjected
to analysis. Of these 5 cases, en bloc resection was completed
in one case, piecemeal resection was performed in 2 cases,
and endoscopic treatment was suspended in 2 cases.
4.Discussion
Compared with conventional surgery, endoscopic treatment
has the advantage of being less invasive and less costly
[16]. Large superﬁcial tumors in the colon and rectum have
little tendency toward vertical growth despite their lateral
extension; therefore, endoscopic resection is supposed to be
preferable [11]. This means that colorectal ESD, a minimally
invasive technique in colorectal cancer, is now playing an
important role in the treatment of large superﬁcial colorectal
tumors.
Eight clinical studies regarding the eﬃciency and safety
of ESD in the colon and rectum have been reported thus
far between 2007 and 2010 [2–9], all from Japan. In these
eight studies, the en blocresection rate incolorectal ESD was
reported to be 80–98.6%, and the complete resection rate
was 70–98.6%. In our study, the rate of en bloc resection
was 89.1% (122/137), and the rate of complete resection
was 85.4% (117/137), similar to the previous reports. This
is probably because the technique of ESD in the colon and
rectum is in common with gastric ESD, and endoscopistscan4 International Journal of Surgical Oncology
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Figure 2: A case of ESD failure. (a) Residual mucosal lesion after EMR located in the hepatic ﬂexure of the colon. (b) Non-lifting sign was
positive after submucosal injection. (c) Submucosal layer was clearly visualized after incision. (d) Severe submucosal ﬁbrosis existed under
the lesion. ESD procedure was suspended to avoid perforation.
Table 2: Clinicopathologic characteristics of 5 suspended cases.
No. Age Sex Location Size mm Gross type Depth Diagnosis History of
biopsy/ET
NLS Cause of suspend Additional therapy
1. 69 M Ascending 20 LST SM2 Adenoca. EMR/APC + Severe ﬁbrosis Scheduled LS
2. 77 M Transverse 15 IIa+IIc SM1 Adenoca. EMR + Severe ﬁbrosis Scheduled LS
3. 68 M Sigmoid 20 IIa M Adenoca. biopsy + Severe ﬁbrosis Scheduled LS
4. 65 M Transverse 22 LST M Adenoca. biopsy + Severe ﬁbrosis Scheduled LS
5. 58 M Sigmoid 20 IIc M Adenoca. biopsy + Perforation Emergency Surgery
ET: Endoscopic Therapy, NLS: Non-lifting Sign, LS: Laparoscopic Surgery, Adenoca.: Adenocarcinoma.
M: intramucosal cancer.
SM1: submucosalinvasion less than 1000µmf r o mt h em u s c u l a r i sm u c o s a e .
SM2: submucosalinvasion1000µm or more fromthe muscularismucosae.
experience gastric ESD procedure to some extent before they
started ESD in the colon and rectum. On the other hand,
the rate of perforation in the previous eight reports ranged
1.4–10.4%, while the rate of perforation in our data was
3.6%, better than the average level of these reports. Because
diﬀerent knives were used in each of the eight previous
r e p o r t s ,t h ec h o i c eo fk n i f em a yb ei np a r tr e l a t e dt ot h er a t e
of perforation in each experience, including our results.
Among the 5 cases that failed to complete the ESD pro-
cedure, 4 were suspended due to severe ﬁbrosis (Figure 2).
It is well known that either biopsy from the lesion or a
previous history of endoscopic treatment can often cause
submucosal ﬁbrosis. Indeed, two of the ﬁve suspended
cases had a previous history of endoscopic treatment at the
same location, ESD was attempted for recurrent lesions,
and perforation also occurred in one of the ﬁve cases, in
agreement with the report by Isomoto et al. [6] that the
ﬁnding of ﬁbrosis was one of the major risk factors of
perforation. Magniﬁed endoscopic observation with NBI
or crystal violet staining is necessary to perform successfulInternational Journal of Surgical Oncology 5
Table 3: Indicationof endoscopicsubmucosaldissection (ESD) for
colorectal tumor.
(1) Lesions that were larger than 20mm in diameter in which en
blocresectionusingsnareEMRisdiﬃcult,althoughitisindicative
for endoscopic treatment
(i) Non-granular LST, particularly those of the pseudo-
depressed type
(ii) Lesions with Vi type pit pattern
(iii) Carcinoma with submucosal inﬁltration
(iv) Large depressed type lesion
(v) Large lesions with elevated type suspected to be cancer†
(2) Mucosallesionswith ﬁbrosis caused by prolapse due to biopsy
or peristalsis of the lesions
(3) Sporadic localized tumors in chronic inﬂammation such as
ulcerative colitis
(4) Local residual early cancer after endoscopic resection
†Including granular LST that consisted of large nodules.
EMR: endoscopic mucosalresection, LST: laterally spreading tumor.
ESD.It allows discrimination between benign and malignant
tumors and predicts the tumor inﬁltration depth [17–
20], and precise diagnosis before ESD may lead to good
strategies for ESD and can also reduce the risk of perforation
in colorectal ESD. Nevertheless, it is diﬃcult to predict
submucosalﬁbrosis. Thus,informationonthepasthistory of
biopsies or endoscopic treatment is important in each case.
Endoscopic treatment of residual lesions, positive for a
non-lifting sign due to the previous endoscopic treatment, is
technically much more diﬃcult. In our study, we attempted
endoscopic resection for 5 cases. Complete resection was
achieved in only one case, 2 cases were treated as piecemeal
resection,andwesuspendedendoscopictreatmentin2cases;
therefore, the choice of ESD for residual tumor requires
caution.
Minimally invasive, laparoscopically assisted surgery was
ﬁrst considered in 1990 for patients undergoing colectomy
for cancer [21]. The ﬁrst laparoscopic surgery for colorectal
cancer in Japan was reported in 1992. In the early phase,
many cases were indicated for early cancer. The number
of operations has been increasing each year, and now even
some advanced cases undergo laparoscopic surgery [22].
There have been several randomized, controlled studies to
determine the value of laparoscopic resection for colorectal
cancer, and their results have been reported, showing the
short-term results of laparoscopic surgery to be superior and
survival to be almost equivalent to open operations [21, 23].
In Japan, the Japan Society for Cancer of the Colon and Rec-
tum (JSCCR) recommended that clinical Stage I or II cancer
located in the cecum, left- or right-sided colon cancer and
rectosigmoid cancer are good indications for laparoscopic
surgery. On the other hand, obese patients, patients with
a history of abdominal surgery, or a tumor located in the
transverse colon/rectum, are considered diﬃcult cases for
laparoscopic resection. These cases can be good candidates
for colorectal ESD if they fulﬁll the indications for colorectal
ESD.
In conclusion, our study conﬁrmed, in agreement with
previous reports, that colorectal ESD is developing with
favorable results. It is a feasible technique and is gradually
being established as a standard procedure for the large
superﬁcial colorectal tumors.
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